Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 4
2006 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Targeting histone deacetylase in cancer therapy.
Lin HY, Chen CS, Lin SP, Weng JR, Chen CS. Lin HY, et al. Med Res Rev. 2006 Jul;26(4):397-413. doi: 10.1002/med.20056. Med Res Rev. 2006. PMID: 16450343 Review.
Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma.
Shiau CW, Yang CC, Kulp SK, Chen KF, Chen CS, Huang JW, Chen CS. Shiau CW, et al. Cancer Res. 2005 Feb 15;65(4):1561-9. doi: 10.1158/0008-5472.CAN-04-1677. Cancer Res. 2005. PMID: 15735046 Free article.
Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance.
Tseng PH, Lin HP, Zhu J, Chen KF, Hade EM, Young DC, Byrd JC, Grever M, Johnson K, Druker BJ, Chen CS. Tseng PH, et al. Blood. 2005 May 15;105(10):4021-7. doi: 10.1182/blood-2004-07-2967. Epub 2005 Jan 21. Blood. 2005. PMID: 15665113 Free PMC article.
3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells.
Kulp SK, Yang YT, Hung CC, Chen KF, Lai JP, Tseng PH, Fowble JW, Ward PJ, Chen CS. Kulp SK, et al. Cancer Res. 2004 Feb 15;64(4):1444-51. doi: 10.1158/0008-5472.can-03-2396. Cancer Res. 2004. PMID: 14973075 Free article.
Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes.
Chen CS, Weng SC, Tseng PH, Lin HP, Chen CS. Chen CS, et al. J Biol Chem. 2005 Nov 18;280(46):38879-87. doi: 10.1074/jbc.M505733200. Epub 2005 Sep 26. J Biol Chem. 2005. PMID: 16186112 Free article.
Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells.
Huang JW, Shiau CW, Yang YT, Kulp SK, Chen KF, Brueggemeier RW, Shapiro CL, Chen CS. Huang JW, et al. Mol Pharmacol. 2005 Apr;67(4):1342-8. doi: 10.1124/mol.104.007732. Epub 2005 Jan 13. Mol Pharmacol. 2005. PMID: 15653552
Development of small-molecule cyclin D1-ablative agents.
Huang JW, Shiau CW, Yang J, Wang DS, Chiu HC, Chen CY, Chen CS. Huang JW, et al. J Med Chem. 2006 Jul 27;49(15):4684-9. doi: 10.1021/jm060057h. J Med Chem. 2006. PMID: 16854074